BioInvent Has Received Milestones From Bayer Pharma S.A. And Servier

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LUND, Sweden--(BUSINESS WIRE)--Regulatory News:

BioInvent (STO:BINV)

BioInvent International (OMXS: BINV) today announced that it has received two separate milestone payments, together worth 1 MEuro, as a result of milestones being reached under collaborations with Bayer Pharma AG (Bayer) and Servier.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC